SSG
LKFT

Summit Securities Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Summit Securities Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,234
Closed -$230K – 1149
2025
Q2 		$230K Buy
+8,234
New +$221K 0.04% 245
2024
Q1 		– Sell
-46
Closed -$2K – 644
2023
Q4 		$2K Sell
46
-140
-75% -$5.15K ﹤0.01% 617
2023
Q3 		$6K Buy
+186
New +$7.24K ﹤0.01% 453

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Summit Securities Group's LKFT Position: Q3 2025 in Review

Summit Securities Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2025, closing a stake of 8,234 shares — an estimated $230K sold.

Summit Securities Group first reported a position in LKFT in Q3 2023 and held it in 3 quarters. The position peaked at $230K in Q2 2025. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2025.

  • Summit Securities Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 8,234 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2025, an estimated $230K.
  • Summit Securities Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2023 and held it in 3 quarters.
  • Summit Securities Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $230K in Q2 2025.
  • 92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.